Description

KRM Ayurveda Limited's equity shares to be listed on NSE EMERGE SME Platform with effect from January 29, 2026, with initial trading in Trade for Trade Surveillance Segment.

Summary

National Stock Exchange of India has announced the listing of equity shares of KRM Ayurveda Limited on the EMERGE SME Platform effective January 29, 2026. The company’s 21,260,800 equity shares of Rs. 10/- face value (issued at Rs. 135/- per share) will be available for trading under the symbol ‘KRMAYURVED’ with ISIN INE1MTV01019. Initially, the security will trade in Series ‘ST’ (Trade for Trade Surveillance Segment with Settlement Type ‘W’) before transitioning to Series ‘SM’ (Normal Rolling Segment) as per SEBI guidelines.

Key Points

  • Trading Symbol: KRMAYURVED (Series ST - Trade for Trade Surveillance Segment)
  • ISIN: INE1MTV01019
  • Issue Details: 21,260,800 equity shares of Rs. 10/- face value at Rs. 135/- per share
  • Market Lot: 1,000 equity shares
  • Distinctive Number Range: 1 to 21,260,800
  • Market Maker Spread: Maximum 10%
  • Market Type: Continuous Market with Pari Passu status
  • Pre-Open Session: Security will be part of IPO and Other category pre-open session
  • Two appointed Market Makers: Mansi Share and Stock Broking Private Limited and Nikunj Stock Brokers Limited

Regulatory Changes

No new regulatory changes introduced. The listing follows existing SEBI circular guidelines:

  • SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 (IPO pre-open session and segment migration)
  • Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018 (continuous market trading)

Compliance Requirements

  • Members: Must note the security will be identified by designated codes only
  • Trading: Must be conducted in specified lot sizes (1,000 equity shares)
  • Settlement: Initial settlement type ‘W’ in Trade for Trade Surveillance Segment
  • Lock-in: As per Annexure I (specific lock-in details apply to certain shares based on distinctive numbers)
  • Market Makers: Must maintain spread within 10% and adhere to minimum and maximum quantity requirements

Important Dates

  • Effective Date: January 29, 2026
  • Circular Issue Date: January 28, 2026
  • Circular Reference: NSE/CML/72509, Circular No. 0141/2026
  • Financial Year: April 2025 - March 2026

Impact Assessment

Market Impact: Low - This is a standard SME IPO listing with limited impact on the broader market. The listing affects only the SME segment of NSE’s EMERGE platform.

Operational Impact: Medium for SME segment participants - Trading members dealing in SME securities need to configure systems for the new symbol, ISIN, and lot size. The Trade for Trade Surveillance Segment classification requires special attention to settlement processes.

Investor Impact: Relevant for SME investors and those interested in the Ayurveda/FMCG sector. The 10% face value with Rs. 135/- issue price represents a 1,250% premium, which is typical for SME IPOs but requires careful valuation consideration.

Company Details:

  • Registered Office: A-16, G T Karnal Road Industrial Area, North West, Delhi - 110033
  • Compliance Officer: Ms. Pooja Garg (compliance@krmayurveda.com)
  • Registrar: Skyline Financial Services Private Limited
  • Contact: +91-9289101700

Impact Justification

Standard SME IPO listing with limited market-wide impact, relevant primarily to SME segment participants and the specific company